Volume 37, Issue 5, 2022-5-1, Pages A1-A13

Articles in this issue:

1. Editorial Board

2. Masthead

3. Table of Contents

4. Time-Driven Activity-Based Costing in Preoperative Tasks for Total Hip and Knee Arthroplasty

5. Demand Matching Total Joint Replacement Patients Results in Reduction of Post-Discharge Costs

6. Orthopedic Specialty Hospital Reasons for Transfer and Subsequent Outcomes

7. Does In-Hospital Opioid Use Affect Opioid Consumption After Total Joint Arthroplasty?

8. Midterm Survivorship of Robotic-Assisted Lateral Unicompartmental Knee Arthroplasty

9. Defining Clinically Meaningful Thresholds for Patient-Reported Outcomes in Knee Arthroplasty

10. Does Nefopam Provide Analgesic Effect and Reduce Morphine Consumption After Primary Total Knee Arthroplasty? A Prospective, Double-Blind, Randomized Controlled Trial

11. Reducing Narcotic Usage With 0.5% Bupivacaine Periarticular Injections in Total Knee Arthroplasty

12. Higher Tissue Concentrations of Vancomycin Achieved With Low-Dose Intraosseous Injection Versus Intravenous Despite Limited Tourniquet Duration in Primary Total Knee Arthroplasty: A Randomized Trial

13. Negative Association of Subclinical Hypothyroidism on Improvement in Patient-Reported Outcomes After Total Knee Arthroplasty

14. Effect of Total Knee Arthroplasty on Coronal Alignment of the Ankle Joint

15. Projected Prevalence of Obesity in Primary Total Hip Arthroplasty: How Big Will the Problem Get?

16. Patterns and Predictors of Weight Change Before and After Total Hip Arthroplasty in Class 2 and 3 Obese Patients

17. Dexamethasone Attenuates the Perioperative Acute Phase Response for Simultaneous Bilateral Total Hip Arthroplasty

18. Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort

19. Excellent Long-Term Survival Rate of Polished, Tapered, Cemented Stems in Patients Aged 35 Years or Younger With Avascular Necrosis or Inflammatory Arthritis of the Hip

20. Reduced Infection Rate After Aseptic Revision Total Knee Arthroplasty With Extended Oral Antibiotic Protocol

21. Do Modular Dual Mobility Cups Offer a Reliable Benefit? Minimum 5-Year Follow-Up of 102 Cups

22. Indication for Proximal Femoral Replacement Is Associated With Risk of Failure

23. How Does a “Dry Tap” Impact the Accuracy of Preoperative Aspiration Results in Predicting Chronic Periprosthetic Joint Infection?

24. Surgical Helmet Systems Are Associated With a Lower Rate of Prosthetic Joint Infection After Total Knee Arthroplasty: Combined Results From the New Zealand Joint Registry and Surgical Site Infection Improvement Programme

25. Survival and Outcomes of 1.5-Stage vs 2-Stage Exchange Total Knee Arthroplasty Following Prosthetic Joint Infection

26. Bearing Separation From the Lateral Wall of the Tibial Component Is a Risk of Anterior Dislocation of the Mobile Bearing in Oxford Unicompartmental Knee Arthroplasty

27. Increased Morbidity With Diagnosis and Treatment of Pulmonary Embolism After Total Joint Arthroplasty: A Matched Control Analysis of 30,000 Patients

28. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty

29. What Are Drivers of Readmission for Readmission-Requiring Venous Thromboembolic Events After Primary Total Hip Arthroplasty? An Analysis of 544,443 Cases

30. New Classification for Periprosthetic Distal Femoral Fractures Based on Locked-Plate Fixation Following Total Knee Arthroplasty: A Multicenter Study

31. Global Publication Trends and Research Hotspots of Revision Hip and Knee Arthroplasty: A 21-Year Bibliometric Approach

32. Does Implant Design Influence Failure Rate of Lateral Unicompartmental Knee Arthroplasty? A Meta-Analysis

33. The Incidence and Temporal Trends of Dislocation After the Use of Constrained Acetabular Components and Dual Mobility Implants in Primary Total Hip Replacements: A Systematic Review and Meta-Analysis of Longitudinal Observational Studies

34. Clinical Outcomes Following Distal Femur Replacement for Periprosthetic Distal Femur Fractures: A Systematic Review and Meta-Analysis

35. Conflict of Interest Statement